Skip to content

filings.toolsA Dark Vector Cognition product

Item 6. EXHIBITS

11K characters. Original on sec.gov ·

Item 6. EXHIBITS


Number			Description
3.1			Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 29, 2022).
3.2			Bylaws of the Registrant (incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 29, 2022).
10.1			Credit Agreement, dated as of March 27 , 2025, among the Registrant, as the borrower, J PM organ Chase Bank, N.A., as the Administrative A gent , and the le nders party thereto (incorporated by reference to Exhibit 10.1 to t he Regis trant ’s Current Report on Form 8-K filed with the SEC on March 31 , 2025).
10.2			364-Da y R e volving Credit Agreement, dated as of March 27 , 2025, among the Registrant, as the borrower, JPMorgan Chase Bank, N.A., as the Administrative Agent, and the lenders party thereto (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 31 , 2025).
10.3			Employment contract with Roland Rott, dated as of June 3 0, 2024.†
10.4			2 025 GE HealthCare Restric ted St ock Unit Grant Agreement .
10.5			2 025 GE HealthCare Sto ck Option Grant Agreement .
10.6			2025 GE HealthCare Performance Stock Unit Grant Agreem ent.
10.7			2 025 GE He althCare New Hire Restricted Stock Unit Grant Agreement.
10.8			2 025 Global Addendum.
31.1			Certification of the Registrant’s Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2			Certification of the Registrant’s Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1			Certifications of the Registrant’s Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101			The following materials from GE HealthCare Technologies Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in inline XBRL (eXtensible Business Reporting Language); (1) Condensed Consolidated Statements of Income for the three months ended March 31, 2025 and 2024; (2) Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024; (3) Condensed Consolidated Statements of Financial Position as of March 31, 2025 and December 31, 2024; (4) Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2025 and 2024; (5) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and 2024; and (6) Notes to the Condensed Consolidated Financial Statements.
104			Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
†			Certain portions of this exhibit have been redacted pursuant to Item 601(b)(2)(ii) or Item 601(b)(10)(iv) of Regulation S-K, as applicable. The Company agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon its request.

T able of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


						GE HealthCare Technologies Inc.
						(Registrant)

April 30, 2025						/s/ George A. Newcomb
Date						George A. Newcomb, Controller & Chief Accounting Officer (authorized signatory)

Previous: Item 5. OTHER INFORMATION